1991年至2019年的班夫分类。对我们理解和报告同种异体肾活检的重大贡献。
Banff Classification from 1991 to 2019. A Significant Contribution to Our Understanding and Reporting of Allograft Renal Biopsies.
作者信息
Gowrishankar Swarnalata
机构信息
Department of Histopathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India.
出版信息
Indian J Nephrol. 2022 Jan-Feb;32(1):1-7. doi: 10.4103/ijn.IJN_270_20. Epub 2022 Jan 5.
Abstract
The Banff schema of classification of renal allograft biopsies, first proposed at the meeting in Banff, Canada in 1991 has evolved through subsequent meetings held once in two years and is the internationally accepted scheme of classification which is consensual, current, validated and in clinical use. This review traces the evolution of the classification and our understanding of renal transplant pathology, with emphasis on alloimmune reactions. The proceedings of the meetings and the important studies which have shaped the classification are covered.
摘要
1991年在加拿大班夫举行的会议上首次提出的肾移植活检组织学分类的班夫标准，在随后每两年举行一次的会议中不断发展，是国际公认的、经协商一致、与时俱进、经过验证且在临床中使用的分类方案。本综述追溯了该分类的演变以及我们对肾移植病理学的理解，重点是同种免疫反应。涵盖了各次会议的议程以及对该分类产生影响的重要研究。
相似文献
1
Banff Classification from 1991 to 2019. A Significant Contribution to Our Understanding and Reporting of Allograft Renal Biopsies.1991年至2019年的班夫分类。对我们理解和报告同种异体肾活检的重大贡献。
Indian J Nephrol. 2022 Jan-Feb;32(1):1-7. doi: 10.4103/ijn.IJN_270_20. Epub 2022 Jan 5.
2
Development of Banff Classification from 1991 to 2019 for identifying renal allograft rejection: A narrative review for nephrologists.从 1991 年到 2019 年，Banff 分类法的发展用于识别肾移植排斥反应：为肾病学家提供的叙述性综述。
J Pak Med Assoc. 2022 Aug;72(8):1615-1621. doi: 10.47391/JPMA.3987.
3
An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.早期肾移植活检的Banff分类评估及其与预后的相关性。
Nephrol Dial Transplant. 1999 Oct;14(10):2364-9. doi: 10.1093/ndt/14.10.2364.
4
The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians.用于诊断肾移植排斥反应的班夫分类方案的演变及其对临床医生的意义。
Indian J Nephrol. 2010 Jan;20(1):2-8. doi: 10.4103/0971-4065.62086.
5
The Banff 97 working classification of renal allograft pathology.肾移植病理的班夫97工作分类法。
Kidney Int. 1999 Feb;55(2):713-23. doi: 10.1046/j.1523-1755.1999.00299.x.
6
Banff schema for grading liver allograft rejection: utility in clinical practice.用于肝脏同种异体移植排斥反应分级的班夫标准：在临床实践中的效用
Liver Transpl Surg. 1999 Jul;5(4):261-8. doi: 10.1002/lt.500050418.
7
Evolution of human kidney allograft pathology diagnostics through 30 years of the Banff classification process.通过30年的班夫分类过程看人类肾移植病理诊断的演变
World J Transplant. 2023 Sep 18;13(5):221-238. doi: 10.5500/wjt.v13.i5.221.
8
A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.使用班夫标准对肾移植病理进行的盲法回顾性分析：对临床管理的意义。
Transplantation. 1999 Sep 15;68(5):642-5. doi: 10.1097/00007890-199909150-00008.
9
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.肾移植排斥反应组织学诊断标准的国际标准化：肾移植病理学的班夫工作分类法
Kidney Int. 1993 Aug;44(2):411-22. doi: 10.1038/ki.1993.259.
10
Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection.目前可用于诊断肾移植排斥反应的肾病理学有用免疫组化标志物。
Nephrology (Carlton). 2015 Jul;20 Suppl 2:9-15. doi: 10.1111/nep.12460.
引用本文的文献
1
Evolution of human kidney allograft pathology diagnostics through 30 years of the Banff classification process.通过30年的班夫分类过程看人类肾移植病理诊断的演变
World J Transplant. 2023 Sep 18;13(5):221-238. doi: 10.5500/wjt.v13.i5.221.
本文引用的文献
1
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection.《2019 年班夫肾脏会议报告（一）：T 细胞和抗体介导排斥反应标准的更新和澄清》。
Am J Transplant. 2020 Sep;20(9):2318-2331. doi: 10.1111/ajt.15898. Epub 2020 May 28.
2
Does tubulitis without interstitial inflammation represent borderline acute T cell mediated rejection?tubulitis 而无间质炎症是否代表界线性急性 T 细胞介导的排斥反应？
Am J Transplant. 2019 Jan;19(1):132-144. doi: 10.1111/ajt.14888. Epub 2018 Jun 15.
3
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.Banff 2017 年会肾脏报告：慢性活动性 T 细胞介导排斥反应、抗体介导排斥反应的修订诊断标准，以及下一代临床试验综合终点的前景。
Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.
4
The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.移植肾中炎症性纤维化的病因、意义和后果：Banff i-IFTA 病变。
Am J Transplant. 2018 Feb;18(2):364-376. doi: 10.1111/ajt.14609. Epub 2018 Jan 3.
5
T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.T 细胞介导的排斥反应是导致肾移植疤痕区域炎症的主要决定因素。
Am J Transplant. 2018 Feb;18(2):377-390. doi: 10.1111/ajt.14565. Epub 2017 Nov 21.
6
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.《2015年班夫肾脏会议报告：排斥反应分类的当前挑战及采用分子病理学的前景》
Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.
7
Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies.加速动脉硬化的决定因素和结果：循环抗体的主要影响。
Circ Res. 2015 Aug 14;117(5):470-82. doi: 10.1161/CIRCRESAHA.117.306340. Epub 2015 Jun 8.
8
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.用于改善早期抗体介导的肾移植排斥反应风险分层的分子显微镜策略
J Am Soc Nephrol. 2014 Oct;25(10):2267-77. doi: 10.1681/ASN.2013111149. Epub 2014 Apr 3.
9
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.班夫 2013 年会议报告：包含 C4d 阴性抗体介导的排斥反应和抗体相关的动脉病变。
Am J Transplant. 2014 Feb;14(2):272-83. doi: 10.1111/ajt.12590.
10
Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).肾移植活检中抗体介导排斥反应的微阵列诊断：一项国际前瞻性研究（INTERCOM）。
Am J Transplant. 2013 Nov;13(11):2865-74. doi: 10.1111/ajt.12465. Epub 2013 Oct 3.
Zotero 插件